New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 23, 2014
08:08 EDTWWWW, SONS, SIRI, FUN, NVAX, AEGR, WRLD, NRF, ORN, ORB, NCS, DY, CR, PLCE, BIG, SPLKSplunk, Big Lots on FBR's list of stocks that can double
FBR Capital compiled a list of stocks it believes can double within two years. The names on the list are: Big Lots (BIG), Children's Place (PLCE), Crane (CR), Dycom (DY), NCI Building Systems (NCS), Orbital Sciences (ORB), Orion Marine (ORN), Northstar Realty (NRF), World Acceptance (WRLD), Aegerion (AEGR), Novavax (NVAX), Cedar Fair (FUN), Sirius XM (SIRI), Sonus Networks (SONS), Splunk (SPLK) and Web.com (WWWW).
News For SPLK;BIG;PLCE;CR;DY;NCS;ORB;ORN;NRF;WRLD;AEGR;NVAX;FUN;SIRI;SONS;WWWW From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
October 15, 2014
08:40 EDTNVAXNovavax RSV F Vaccine study evoked polyclonal antibody response
Novavax announced that its RSV F-protein nanoparticle vaccine candidate, or RSV F Vaccine, evoked a polyclonal antibody response to antigenic site II, the same site targeted by the monoclonal antibody palivizumab, resulting in protection from an RSV challenge in an animal model. Researchers at Novavax reported these findings in an online paper published by Vaccine titled: "An insect cell derived respiratory syncytial virus F nanoparticle vaccine induces antigenic site II antibodies and protects against RSV challenge in cotton rats by active and passive immunization." Greg Glenn, SVP, Research and Development at Novavax stated, "This study further characterizes the immune response to our RSV F Vaccine, including the production of both polyclonal palivizumab competing antibodies that target antigenic site II, as well as other neutralizing antigenic sites on the F-protein. In addition, our ability to assess the safety of our RSV F Vaccine relative to Lot 100 formalin inactivated vaccine, which is known to cause disease enhancement, and to demonstrate that our vaccine's efficacy is equivalent or better than palivizumab, gives us greater confidence that our RSV vaccine candidate will be both safe and effective."
October 14, 2014
16:13 EDTAEGRPoint72 Asset Management reports 5.2% passive stake in Aegerion
Subscribe for More Information
08:40 EDTNVAXNovavax initiates Phase 2 clinical trial of RSV F vaccine
Novavax announced that enrollment has begun in a Phase 2 clinical trial of its respiratory syncytial virus, or RSV, F-protein nanoparticle vaccine candidate, in healthy elderly subjects. The trial is a randomized, observer-blinded, placebo-controlled Phase 2 study scheduled to enroll 1,600 elderly subjects at ten sites in the United States. The trial will evaluate the incidence of all respiratory illnesses due to RSV, including medically-attended respiratory illnesses due to RSV, and hospitalizations for respiratory illness due to RSV in community-living elderly adults who have been treated with placebo. The study will also evaluate the safety and immunogenicity of a 135g dose of the RSV F Vaccine compared with placebo. The trial will also estimate the efficacy of the RSV F Vaccine in reducing the incidence of respiratory illnesses due to RSV.
October 13, 2014
09:23 EDTSPLKHP could buy lower valuation company, says Bernstein
Subscribe for More Information
06:04 EDTSPLKSplunk upgraded to Outperform from Market Perform at William Blair
William Blair upgraded Splunk to Outperform citing better earnings visibility and more reasonable valuation levels.
October 12, 2014
17:20 EDTSPLKGE, Splunk, Cisco, others could benefit from Internet of Things, Barron's says
Subscribe for More Information
October 10, 2014
07:23 EDTSPLKSplunk price target raised to $65 from $56 at Deutsche Bank
Subscribe for More Information
October 9, 2014
14:10 EDTSIRIShazam, Sun Broadcasting to launch customized, interactive radio content
Subscribe for More Information
October 8, 2014
07:17 EDTSPLKSplunk price target raised to $64 from $55 at UBS
Subscribe for More Information
October 7, 2014
10:02 EDTNVAXOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:08 EDTSPLKSplunk, AWS to integrate Hunk on Amazon Elastic MapReduce
Subscribe for More Information
07:05 EDTNVAXNovavax initiated with an Overweight at JPMorgan
JPMorgan says it is impressed by the potential of Novavax's proprietary recombinant nanoparticle vaccine technology. The firm started shares with an Overweight rating and $7 price target.
October 6, 2014
17:23 EDTBIGContainer Store plummets after cutting fiscal 2014 outlook
Subscribe for More Information
14:38 EDTSPLKSplunk received $2.1M from government department says JMP Securities
Subscribe for More Information
14:09 EDTSPLKSplunk, Tableau seen by Morgan as well-positioned in Big Data space
Subscribe for More Information
10:04 EDTSPLKOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:25 EDTSPLKOn The Fly: Pre-market Movers
HIGHER: HP (HPQ), up 5% after confirming plans to separate into two companies... CareFusion (CFN), up 24% after Becton Dickinson (BDX) agreed to acquire the company for $58 per share in $12.2B deal. Becton Dickinson shares are up 7% following the news... Chimerix (CMRX), up 7% after announcing announced that brincidofovir has been provided for potential use in patients with Ebola Virus Disease... Conn's (CONN), up 6.5% after announcing that it is exploring strategic alternatives... TASER (TASR), up 5% after announces multiple orders of TASER Smart Weapons... Tableau (DATA), up 3.5% after upgraded at Morgan Stanley... Splunk (SPLK), up 3.9% after upgraded at Morgan Stanley... Unilife (UNIS), up 52% after signing a 15-year commercial supply agreement with Sanofi (SNY). LOWER: RadioShack (RSH), down 5% after confirming definitive agreements to restructure debt... Alcobra (ADHD), down 43% after announcing results from Phase III study of MDX in adult ADHD... Sunesis (SNSS), down 71% after announcing Phase 3 VALOR trial did not meet primary endpoint... H&R Block Bank (HRB), down 5% after deal with BofI (BOFI) not expected to get regulatory approval this year. Tekmira (TKMR), down 8% after downgraded at Leerink.
07:23 EDTSPLKSplunk to hold a financial analyst meeting
In conjunction with the company's annual users' conference, CFO Conte hosts a financial discussion with investors and financial analysts in Las Vegas on October 7 at 2:15 pm. Webcast Link
07:10 EDTSPLKSplunk to hold a user conference
Subscribe for More Information
05:54 EDTSPLKSplunk upgraded to Overweight from Equal Weight at Morgan Stanley
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use